SCHEMBL1014856

SCHEMBL1014856

O=C(COCC(=O)N(c1ccccc1)C1CCCCC1)Nc1ccc(Cl)cc1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 6/20 0.51
KDM4E B2RXH2 5/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
ALDH1A1 P00352 2/20 0.48
NPC1 O15118 1/20 0.48
MITF O75030 1/20 0.48
RAB9A P51151 1/20 0.48
PAX8 Q06710 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
POLB P06746 4/20 0.48
G6PD P11413 1/20 0.48
TRPM8 Q7Z2W7 1/20 0.45
GAA P10253 1/20 0.45
LMNA P02545 2/20 0.43
MAPT P10636 3/20 0.43
HSD17B10 Q99714 1/20 0.42
TP53 P04637 1/20 0.42
TRPM4 Q8TD43 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1015239 0.99 SERPINE1 (0.50) SERPINE1KDM4EMEN1KMT2AALDH1A1
SCHEMBL1014777 0.92 ALDH1A1 (0.46) SERPINE1KDM4EMEN1KMT2AALDH1A1
SCHEMBL1015240 0.92 MEN1 (0.46) SERPINE1KDM4EMEN1KMT2AALDH1A1
SCHEMBL1015397 0.87 SERPINE1 (0.50) SERPINE1KDM4EMEN1KMT2AALDH1A1
SCHEMBL1013771 0.86 SERPINE1 (0.49) SERPINE1KDM4EMEN1KMT2AALDH1A1
SCHEMBL1798112 0.82 SERPINE1 (0.56) SERPINE1KDM4EMEN1KMT2AALDH1A1
SCHEMBL1797141 0.81 SERPINE1 (0.55) SERPINE1KDM4EMEN1KMT2AALDH1A1
SCHEMBL1015522 0.79 RAB9A (0.55) SERPINE1KDM4EKMT2AALDH1A1NPC1
SCHEMBL1013772 0.78 KMT2A (0.44) SERPINE1KDM4EMEN1KMT2AALDH1A1
SCHEMBL1013555 0.77 KMT2A (0.48) KDM4EMEN1KMT2AALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US claimed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US claimed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP claimed
US-10092537-B2 Use for PAI-1 inhibitor RENASCIENCE CO., LTD. (JP) 2018-10-09 US disclosed
US-20160158188-A1 NOVEL USE FOR PAI-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2016-06-09 US disclosed
EP-2990057-A1 NOVEL USE FOR PAI-1 INHIBITOR Renascience Co., Ltd. (JP) 2016-03-02 EP disclosed
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 SERPINE1 1/4885KDM4E 4108/4885MEN1 892/4885
US-20160158188-A1 NOVEL USE FOR PAI-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 SERPINE1 1/4885KDM4E 4253/4885MEN1 1229/4885
US-10092537-B2 Use for PAI-1 inhibitor SERPINE1, SERPINC1, SERPINB1 SERPINE1 1/4885KDM4E 4348/4885MEN1 1187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.